vimarsana.com
Home
Live Updates
Neoadjuvant Versus Adjuvant Therapy in Resectable NSCLC : vi
Neoadjuvant Versus Adjuvant Therapy in Resectable NSCLC : vi
Neoadjuvant Versus Adjuvant Therapy in Resectable NSCLC
A panel of experts offers their insights into which patients with resectable early-stage NSCLC might be suitable for neoadjuvant versus adjuvant chemoimmunotherapy.
Related Keywords
,
Recent Updates ,
Translating Evidence ,
Clinical Practice ,
Versus Adjuvant Therapy ,
Nsclc ,
Early Nsclc ,
Non Small Cell Lung Cancer ,
Asco 2023 ,
Localized Disease ,
Presection ,
Surgery ,
Staging ,
Chemoimmunotherapy ,
Immunotherapy ,
Ohio ,
Molecular Testing ,
Liquid Biopsy ,
Tissue Biopsy ,
Ngs Testing ,
Egfr ,
Talk ,